Exploring the Impact of Evidence-based Medicine on Medical Knowledge Management Capability and Medical Value Innovation Performance

• Main Authors: Ya-hang Chuang, 莊亞航
• Other Authors: Sho-Fang Chang
• Format: Others
• Language: zh-TW
• Published: 2009
• Online Access: http://ndltd.ncl.edu.tw/handle/5773vs

碩士 === 嘉南藥理科技大學 === 醫療資訊管理研究所 === 97 === Evidence-based medicine (EBM) is an important element of implementing medical knowledge management. Both of them are also critical ways of medical value innovation. Nevertheless, there is rare research concerning the influence of EBM on medical knowledge management capability and medical value innovation performance, nor is the research on the measurements of those constructs. Therefore, this study aims to develop measurements on the degree of practicing EBM, medical knowledge management capability and medical value innovation performance, and also to discuss the interactions among the three constructs. Survey was performed toward physicians positioning in four medical centers. 320 questionnaires were mailed and 204 effective were responded, reaching 63.75% of effective response rate. Exploratory factor analysis and PLS were conducted to analyze the data and verify the research model. The study develops three dimensions on the practice of EBM, including the capability of practicing EBM, doing researching by EBM, and making clinical decision by EBM. Medical knowledge management capability is also defined by four factors including knowledge sharing capability, knowledge accumulation capability, knowledge utilization capability and knowledge creation capability. Our study finds that EBM practice has positive influence on medical knowledge management capability and medical value innovation performance. Medical knowledge management capability has partial moderating effect on EBM practice and medical value innovation performance. In addition, knowledge utilization capability and knowledge creation capability have largest contribution on medical value innovation performance. Knowledge accumulation capability, otherwise, is a barrier to medical value innovation.